4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001250853-14-000041
$SLSCIK 0001390478operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:44 PM ET
Size
5.3 KB
Accession
0001250853-14-000041
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Sale
Common Stock
2014-01-30$5.57/sh−100,000$556,500→ 409,665 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.63 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 8:44 PM ET
- Size
- 5.3 KB